These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Requirement of B7-mediated costimulation in the induction of experimental autoimmune anterior uveitis. Shao H; Woon MD; Nakamura S; Sohn JH; Morton PA; Bora NS; Kaplan HJ Invest Ophthalmol Vis Sci; 2001 Aug; 42(9):2016-21. PubMed ID: 11481266 [TBL] [Abstract][Full Text] [Related]
8. Role of the B7-CD28/CTLA-4 pathway in autoimmune disease. Chang TT; Kuchroo VK; Sharpe AH Curr Dir Autoimmun; 2002; 5():113-30. PubMed ID: 11826754 [No Abstract] [Full Text] [Related]
9. Studies in B7-deficient mice reveal a critical role for B7 costimulation in both induction and effector phases of experimental autoimmune encephalomyelitis. Chang TT; Jabs C; Sobel RA; Kuchroo VK; Sharpe AH J Exp Med; 1999 Sep; 190(5):733-40. PubMed ID: 10477557 [TBL] [Abstract][Full Text] [Related]
10. Long-term inhibition of murine experimental autoimmune encephalomyelitis using CTLA-4-Fc supports a key role for CD28 costimulation. Cross AH; Girard TJ; Giacoletto KS; Evans RJ; Keeling RM; Lin RF; Trotter JL; Karr RW J Clin Invest; 1995 Jun; 95(6):2783-9. PubMed ID: 7539461 [TBL] [Abstract][Full Text] [Related]
11. The B7-CD28/CTLA-4 costimulatory pathways in autoimmune disease of the central nervous system. Anderson DE; Sharpe AH; Hafler DA Curr Opin Immunol; 1999 Dec; 11(6):677-83. PubMed ID: 10631554 [TBL] [Abstract][Full Text] [Related]
12. B7/CD28 costimulation is essential for the homeostasis of the CD4+CD25+ immunoregulatory T cells that control autoimmune diabetes. Salomon B; Lenschow DJ; Rhee L; Ashourian N; Singh B; Sharpe A; Bluestone JA Immunity; 2000 Apr; 12(4):431-40. PubMed ID: 10795741 [TBL] [Abstract][Full Text] [Related]
13. Role of B7:CD28/CTLA-4 in the induction of chronic relapsing experimental allergic encephalomyelitis. Perrin PJ; Scott D; Quigley L; Albert PS; Feder O; Gray GS; Abe R; June CH; Racke MK J Immunol; 1995 Feb; 154(3):1481-90. PubMed ID: 7529805 [TBL] [Abstract][Full Text] [Related]
14. T cells are the main cell type expressing B7-1 and B7-2 in the central nervous system during acute, relapsing and chronic experimental autoimmune encephalomyelitis. Cross AH; Lyons JA; San M; Keeling RM; Ku G; Racke MK Eur J Immunol; 1999 Oct; 29(10):3140-7. PubMed ID: 10540325 [TBL] [Abstract][Full Text] [Related]
15. The complexity of the B7-CD28/CTLA-4 costimulatory pathway. Schweitzer AN; Sharpe AH Agents Actions Suppl; 1998; 49():33-43. PubMed ID: 9426826 [TBL] [Abstract][Full Text] [Related]
16. A critical role for B7/CD28 costimulation in experimental autoimmune encephalomyelitis: a comparative study using costimulatory molecule-deficient mice and monoclonal antibody blockade. Girvin AM; Dal Canto MC; Rhee L; Salomon B; Sharpe A; Bluestone JA; Miller SD J Immunol; 2000 Jan; 164(1):136-43. PubMed ID: 10605004 [TBL] [Abstract][Full Text] [Related]
17. The CD28-B7 costimulatory pathway and its role in autoimmune disease. Daikh D; Wofsy D; Imboden JB J Leukoc Biol; 1997 Aug; 62(2):156-62. PubMed ID: 9261329 [TBL] [Abstract][Full Text] [Related]
18. Targeting T cell costimulation in autoimmune disease. Stuart RW; Racke MK Expert Opin Ther Targets; 2002 Jun; 6(3):275-89. PubMed ID: 12223069 [TBL] [Abstract][Full Text] [Related]